GI Surgery – Biliary Tract and Pancreas
Cohort Study | Impact of complications after resection of pancreatic cancer on disease recurrence and survival
10 Apr, 2023 | 13:34h | UTC
Commentary on Twitter
Major complications after🦀surgery are known to impair DF- and OS ➡️📜of all 🇳🇱 pat undergoing panc surgery 2014–2017 (n=1071) confirms via causal mediation 📈that this is mediated due to omission of adjuvant CTX!https://t.co/8kjr9MpRt4#some4surgery #some4hpb @BJSAcademy pic.twitter.com/EZd7Yvi4z2
— BJS Open (@BjsOpen) April 1, 2023
Brief Review | What every gastroenterologist should know about gastrointestinal neuroendocrine tumors
4 Apr, 2023 | 13:29h | UTC
Cohort Study | Celiac axis stenosis is an underestimated risk factor for increased morbidity after pancreatoduodenectomy
4 Apr, 2023 | 13:20h | UTC
Update on the management of acute pancreatitis
30 Mar, 2023 | 14:10h | UTCUpdate on the management of acute pancreatitis – Current Opinion in Critical Care
Related:
Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis – New England Journal of Medicine
Acute Pancreatitis: Diagnosis and Treatment – Drugs
Evidence-Based Disposition of Acute Pancreatitis – emDocs
Pancreatitis – National Institute for Health and Care Excellence
Research: Endoscopic or Surgical Step-up Approach for Infected Necrotising Pancreatitis
Evidence-Based Approach to the Surgical Management of Acute Pancreatitis – The Surgery Journal
RCT | Efficacy and safety of colesevelam for the treatment of bile acid diarrhea
30 Mar, 2023 | 14:06h | UTCEfficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary on Twitter
New research – Borup et al – Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo controlled, phase 4 clinical trialhttps://t.co/m1r0heRgjX#gitwitter #BAD #diarrhoea pic.twitter.com/zk1TnZFS6b
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) February 7, 2023
M-A | Aggressive IV hydration may increase mortality risk in severe acute pancreatitis
29 Mar, 2023 | 13:26h | UTCSummary: This systematic review and meta-analysis investigated the outcomes of aggressive and non-aggressive intravenous hydration in patients with severe and non-severe acute pancreatitis (AP). The study included nine randomized controlled trials with a total of 953 participants.
The findings revealed that aggressive intravenous hydration significantly increased mortality risk in severe AP cases, and fluid-related complication risk in both severe and non-severe AP cases. However, the study has some limitations, as only one study with 249 participants was judged to have a low risk of bias in all domains, while the remaining eight studies had non-low risk of bias, raising concerns about the reliability of the findings.
Despite these concerns, the findings still suggest that more conservative intravenous fluid resuscitation protocols for AP may be preferable. Further research with more rigorous study designs is needed to provide robust evidence on the effectiveness of different intravenous hydration strategies in treating acute pancreatitis.
M-A | Analgesic effect of erector spinae plane block in adults undergoing laparoscopic cholecystectomy
21 Mar, 2023 | 13:06h | UTC
Cohort Study | A simple classification of pancreatic duct size and texture predicts the risk of postoperative pancreatic fistula
10 Mar, 2023 | 14:10h | UTCRelated:
M-A | Perioperative interventions to reduce pancreatic fistula following pancreatoduodenectomy.
Commentary on Twitter
NEW classification from @ISGPS_news for reporting of pancreatoduodenectomy trials:
A – not-soft (hard) texture and duct >3 mm 😀
B – not-soft (hard) texture and duct ≤3 mm 🙂
C – soft texture and duct >3 mm 😕
D – soft texture and duct ≤3 mm 😬https://t.co/sZeL3MAva2— Pascal Probst (@ProbstPascal) May 1, 2021
RCT | Tranexamic acid did not significantly reduce blood loss in pancreaticoduodenectomy
10 Mar, 2023 | 14:05h | UTCTranexamic acid and blood loss in pancreaticoduodenectomy: TAC-PD randomized clinical trial – British Journal of Surgery (link to abstract – $ for full-text)
ACG Guideline | Diagnosis and management of biliary strictures
3 Mar, 2023 | 14:13h | UTC
Review | Platelet aggregation inhibitors and anticoagulants in gastroenterological and visceral surgical procedures
1 Mar, 2023 | 14:03h | UTC
Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP
1 Mar, 2023 | 13:56h | UTC
Commentary on Twitter
Setting the standards 📐 of common bile duct and pancreatic duct
🌱 CBD up to 8 mm < 65 y/o and up to 11 mm in ≥65 y/o
🍡 PD diameters up to 3 mm in <65 y/o and up to 4 mm in ≥65 y/o
Landmark open access @Gut_BMJ paper 👏 kudos to authors ! 👉https://t.co/hGEkfeVeRc pic.twitter.com/E4IXU50EZi
— Giovanni Marchegiani (@Gio_Marchegiani) February 28, 2023
RCT | Effect of the use of reinforced stapling on the occurrence of pancreatic fistula after distal pancreatectomy
9 Feb, 2023 | 13:34h | UTCEffect of the Use of Reinforced Stapling on the Occurrence of Pancreatic Fistula After Distal Pancreatectomy: Results of the REPLAY (Reinforcement of the Pancreas in distaL pAncreatectomY) Multicenter Randomized Clinical Trial – Annals of Surgery (link to abstract – $ for full-text)
Post-transplant biliary complications: advances in pathophysiology, diagnosis, and treatment
3 Feb, 2023 | 14:01h | UTC
M-A | Major complications and mortality after resection of intrahepatic cholangiocarcinoma
3 Feb, 2023 | 13:43h | UTC
RCT | Disposable elevator cap duodenoscopes reduce microbial contamination during ERCP
30 Jan, 2023 | 00:49h | UTC
Commentary on Twitter
In this RCT of 520 ERCP patients, disposable elevator cap duodenoscopes reduced persistent contamination (RR 0.34, 95% CI 0.16–0.75), with no differences in performance (technical success 94.6% vs. 90.7%, P=.13) or safety outcomes. https://t.co/km87WyxsvR
— JAMA Internal Medicine (@JAMAInternalMed) January 26, 2023
M-A | The optimal timing and intervention to reduce mortality for necrotizing pancreatitis
30 Jan, 2023 | 00:44h | UTCRelated:
Research: Endoscopic or Surgical Step-up Approach for Infected Necrotising Pancreatitis
Evidence-Based Approach to the Surgical Management of Acute Pancreatitis – The Surgery Journal
Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis – New England Journal of Medicine (link to abstract – $ for full-text)
Acute Pancreatitis: Diagnosis and Treatment – Drugs
Evidence-Based Disposition of Acute Pancreatitis – emDocs
Pancreatitis – National Institute for Health and Care Excellence
M-A | Does neoadjuvant treatment in resectable pancreatic cancer improve overall survival?
17 Jan, 2023 | 13:07h | UTC
Establishment and external validation of neutrophil-to-lymphocyte ratio in excluding postoperative pancreatic fistula after pancreatoduodenectomy
17 Jan, 2023 | 12:57h | UTC
M-A | Costs and clinical benefits of enhanced recovery after surgery (ERAS) in pancreaticoduodenectomy
15 Jan, 2023 | 19:58h | UTCRelated:
Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
M-A | Laparoscopic vs. open pancreatoduodenectomy in patients with periampullary tumors
9 Jan, 2023 | 14:02h | UTCLaparoscopic versus Open Pancreatoduodenectomy in Patients with Periampullary Tumors: A Systematic Review and Meta-analysis – Annals of Surgery (link to abstract – $ for full-text)
Phase 2 RCT | Immediate surgery vs. short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer.
14 Dec, 2022 | 15:01h | UTCNews Release: Chemotherapy before surgery can improve survival rates in pancreatic cancer patients – University of Liverpool
Commentary on Twitter
New research – Ghaneh et al – Immediate surgery vs short-course neoadjuvant gemcitabine + capecitabine, FOLFIRINOX, or chemoradiotherapy in patients w/ borderline resectable #pancreaticcancer (ESPAC5): a randomised phase 2 trialhttps://t.co/9S1hupyKjg#gitwitter #onctwitter pic.twitter.com/g2jQUAhUSJ
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) December 14, 2022
Review | Acute and chronic alcoholic pancreatitis, including paraduodenal pancreatitis.
2 Dec, 2022 | 14:08h | UTC
Evidence-based approach to the surgical management of acute pancreatitis.
29 Nov, 2022 | 14:10h | UTCEvidence-Based Approach to the Surgical Management of Acute Pancreatitis – The Surgery Journal
Related:
Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis – New England Journal of Medicine (link to abstract – $ for full-text)
Acute Pancreatitis: Diagnosis and Treatment – Drugs
Evidence-Based Disposition of Acute Pancreatitis – emDocs
Pancreatitis – National Institute for Health and Care Excellence
M-A | Is early laparoscopic cholecystectomy after clearance of common bile duct stones by ERCP superior?
23 Nov, 2022 | 13:44h | UTC